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Abstract
Background—Although the DASH (Dietary Approaches to Stop Hypertension) diet is an
accepted non-pharmacologic treatment for hypertension, little is known about what patient
characteristics affect dietary adherence and what level of adherence is needed to reduce blood
pressure (BP).
Objective—To determine what factors predict dietary adherence and the extent to which dietary
adherence is necessary to produce clinically meaningful BP reductions.
Design—Ancillary study of the ENCORE trial-- a 16-week randomized clinical trial of diet and
exercise.
Participants/setting—Participants included 144 sedentary, overweight or obese adults (BMI’s
25-39.9 kg/m2) with high BP (systolic BP 130-159 and/or diastolic BP 85-99 mm Hg).
Intervention—Patients were randomized to one of 3 groups: DASH diet alone (DASH-A),
DASH diet plus weight management (DASH+WM), and Usual diet controls (UC).
Main outcome measures—Our primary outcomes were a composite index of adherence to the
DASH diet and clinic BP.
Statistical analyses performed—General linear models were used to compare treatment
groups on post-treatment adherence to the DASH diet. Linear regression was used to examine
potential predictors of post-treatment DASH adherence. Analysis of covariance (ANCOVA) was
used to examine the relation of adherence to the DASH diet and BP.
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Results—Participants in the DASH+WM (16.1 SBP [95% CI = 13.0, 19.2], 9.9 DBP [95% CI =
8.1, 11.6] mm Hg) and DASH+A (11.2 SBP [95% CI = 8.1, 14.3], 7.5 DBP [95% CI = 5.8, 9.3]
mm Hg) groups showed significant reductions in BP in comparison with UC participants (3.4 SBP
[95% CI = 0.4, 6.4], DBP 3.8 [95% CI = 2.2, 5.5] mm Hg). Greater post-treatment consumption of
DASH foods was noted in both the DASH-A (M=6.20 [95% CI = 5.83, 6.57]) and DASH+WM
groups (M=6.23 [95% CI = 5.88, 6.59]) compared to UC (M=3.66 [95% CI = 3.30, 4.01]) (p<.
0001), and greater adherence to the DASH diet was associated with larger reductions in clinic SBP
and DBP (p ≤.01). Only ethnicity predicted dietary adherence, with African Americans less
adherent to the DASH diet compared to whites (4.68 [95% CI = 4.34, 5.03] v 5.83 [95% CI =
5.50, 6.11], p< .001).
Conclusions—Greater adherence to the DASH diet was associated with larger BP reductions
independent of weight loss. African Americans were less likely to be adherent to the DASH
dietary eating plan compared to whites, suggesting that culturally sensitive dietary strategies may
be needed to improve adherence to the DASH diet.
Keywords
Hypertension; DASH diet; Blood pressure; Adherence; Psychological testing; Non-
pharmacological treatment
Introduction
A diet that promotes consumption of fruits and vegetables and low fat dairy products, and is
low in fats and cholesterol, known as the ‘The Dietary Approaches to Stop Hypertension’
(DASH) diet, is now recognized as the diet of choice for the prevention and management of
high blood pressure (BP)1 . The DASH diet was established as an effective treatment for
high BP based on findings from the original DASH feeding trials.2,3 Because these feeding
trials provided participants with all meals and snacks, subjects were not responsible for
designing menus, selecting and purchasing food, or preparing meals; as a result, adherence
was excellent and robust reductions in BP were observed.4 In a subsequent study known as
PREMIER5, in which participants were responsible for their own dietary practices, the
DASH diet was associated with greater BP reductions compared to a usual diet, but the
magnitude of the BP reductions for those eating the DASH diet were less than the BP
reductions achieved in the original DASH feeding trials. It was suggested that poorer dietary
adherence in PREMIER compared to the original DASH trials attenuated the effectiveness
of the DASH diet in reducing BP.6
The ENCORE study (Exercise and Nutrition interventions for CardiOvasculaR hEalth)7
extended the PREMIER trial by evaluating the effectiveness of the DASH diet independent
of other recommended lifestyle modifications in lowering BP among individuals with high
BP. Results of ENCORE demonstrated the value of the DASH diet alone and combined with
exercise training and weight reduction in reducing BP and in improving other cardiovascular
biomarkers. The present study presents a secondary analysis of the ENCORE trial in order to
(a) determine the extent to which participants could adhere to the DASH diet in a free-living
situation; (b) identify patient characteristics that were predictive of adherence to the DASH
diet; and (c) examine the relationship between adherence to the DASH diet and the
magnitude of BP reductions.
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The sample was comprised of sedentary, overweight and obese adults (BMI: 25-39.9 kg/m2)
with above optimal BP (SBP 130-159 and/or DBP 85-99 mm Hg). Details of participant
recruitment are provided in our primary publication.7 The protocol was approved by the
Institutional Review Boards at Duke University and the University of North Carolina at
Chapel Hill.
Trial Overview
This is a secondary analysis of the ENCORE clinical trial, which evaluated the effects of 4
months of the DASH diet alone and in combination with a behavioral weight management
program on BP and other cardiovascular biomarkers in 144 individuals with high BP.
Pre- and Post-Intervention Assessments
Clinic blood pressure assessment—Four BP readings were obtained using a standard
mercury sphygmomanometer and stethoscope to determine resting clinic BP.
Ambulatory Blood Pressure Assessment—To assess BP during a typical day,
participants wore an Accutracker II (Suntech Medical Inc, Raleigh, North Carolina)
ambulatory BP monitor that was programmed to record BP measurements 4 times per hour
throughout the waking hours and 2 times per hour during sleep. The mean BP during the
entire 24-hour monitoring period, adjusted for posture, was used for the present analysis.
Cardiorespiratory Fitness—A modified Balke protocol was employed in which
workloads were increased at a rate of 1 metabolic equivalent per minute.8 Participants
underwent amaximal graded exercise treadmill test in which workloads were increased at a
rate of 1 metabolic equivalent per minute. Expired air was collected by mouthpiece for
quantification of cardiopulmonary function with the Parvo Medics TrueOne measurement
system (model 2400; Parvo Medics, Sandy, Utah).
Dietary Assessment
Food Frequency Questionnaire: Dietary habits were assessed at baseline and 16 weeks
post-randomization using a well-validated 114-item, self-administered retrospective food
frequency questionnaire (FFQ)9. The FFQ provided by NutritionQuest (Berkley, CA),
inquired about participants’ average monthly consumption of a comprehensive list of food
items.10,11 The food items were selected based upon dietary recall data from The Third
National Health and Nutrition Examination Survey, Phase III.12
4-Day Food Diary: A food diary was used to gather information about dietary habits,
specifically, macronutrients and caloric intake. Participants kept a detailed food record for
four consecutive days. The data were analyzed using Food Processor SQL Edition software,
version 10.3 (ESHA Research, Salem, Oregon).13
DASH Adherence Score: Dietary adherence was assessed using a scoring scheme adopted
from Folsom and colleagues.14 A composite ‘DASH adherence score’ was generated using
the subscores from 10 equally weighted food and nutrient components (i.e., grains; fruits;
vegetables; nut, seeds, & legumes; dairy; meat; fat; saturated fat; sweets; and sodium). The
selection of the individual components and the generation of the scoring criteria were based
on nutrient intake estimates and daily serving recommendations previously established for
the DASH diet plan (Appendix A). A score of 0-1 was assigned for each dietary component
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and summed across the 10 components to yield the total DASH diet adherence score.
Individuals consuming at or above the recommended number of servings for a particular
food group received a component score of 1; partial credit (0.5pts) was given for intake
levels approaching the recommended level; and zero points were awarded for intake levels
below the minimum target intake recommendation. For example, 1 full point was awarded to
an individual consuming 4 or more servings of vegetables on a typical day; 0.5 points was
awarded for consuming 2-3 servings per day; and 0 points were awarded for anything < 2
servings of vegetables per day. Individual component sub-scores were summed to yield a
composite ‘DASH adherence’ score ranging from 0-10. A score of 10 represented full
adherence to the DASH diet, with a score of 0 reflecting complete non-adherence
Macronutrient and energy data were obtained using the 4-day food diary and food group
serving data were estimated from the FFQ. The dietary intake data from the FFQ was in
‘estimated grams of intake per day’. To derive a measure of servings per day, we defined the
weight in grams of a “serving” of each individual food item listed on the FFQ. The USDA
National Nutrient Database15 was used to determine the gram weights of individual food
servings. Once we defined the number of grams that constituted a standard serving of a food
item, we divided the consumed gram weight by the defined serving amount for the food item
to derive the number of servings consumed per day.
Psychosocial Assessments: Participants completed a battery of psychometric questionnaires
including (1) Beck Depression Inventory-II (BDI-II)16 : a 21-item, self report measure
assessing the presence and severity of depressive symptoms; (2) Spielberger Trait Anxiety
Inventory (STAI-T) 17: a validated 20-item measure of trait anxiety; (3) Multidimensional
Health Locus of Control (MHLC-C) 18: an 18-item, measure assessing participants’ beliefs
about internal and external influences on their health adapted specifically to address issues
of BP control; (4) Perceived Social Support Scale (PSSS) 19: a 12-item measure designed to
assess perceptions concerning the amount of emotional support offered by family, friends,
and significant others; (5) Exercise Self-Efficacy Scale (ESE) 20 : a 5-item measure
designed to assess self-efficacy expectations related to the perceived ability to exercise in
the face of various barriers; and (6) Barrier Scale (BS): a 15-item measure constructed for
this study and designed to assess perceptions concerning potential barriers to successful
participation in all components of the trial (i.e., diet, exercise, attendance at counseling
sessions).
Treatment Groups
Following the completion of baseline assessments, eligible participants were randomized to
one of three groups: DASH plus Behavioral Weight Management (DASH+WM), DASH
Alone (DASH-A), or Usual Diet Control (UC) for 4-months, beginning with a 2-week
structured feeding program in which all patients, regardless of group assignment, were
provided food modeled after the original DASH feeding studies. Following the initial
feeding period, participants in the DASH groups were asked to continue following their
group-specific DASH diet plan on their own for the remaining 14 weeks of the intervention.
DASH Alone (DASH-A)—In the DASH-A group, participants were offered continued
support and feedback during weekly, 30-45 minute group sessions directed by the study
nutritionist. The nutrition intervention curriculum, delivered over the 16 weeks, included an
introduction to the DASH eating plan, as well as information concerning goal setting and
action plans.
DASH plus Behavioral Weight Management (DASH+WM)—Participants in the
DASH+WM group also attended weekly, 30-45 minute group sessions directed by both the
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study nutritionist and study psychologist. The nutrition intervention curriculum, was
identical to that of the DASH-A group, with the addition of calorie restriction, behavior
modification 21,22 , and 30-45 minutes of aerobic exercise three times per week.
Usual Diet Control Group (UC)—The UC group was instructed to maintain their typical
dietary and exercise routines throughout the entirety of the intervention
Data Analysis
General linear models were used to compare treatment groups on post-treatment adherence
to the DASH diet. Each model included the treatment adherence score as the response
variable, and treatment group, ethnicity, gender, age, family income, years of education, and
baseline DASH adherence on the predictor side of the model.
Linear regression was used to examine potential predictors of post-treatment DASH
Adherence. These analyses were limited to participants who were randomized to an active
treatment group (i.e. DASH-A, DASH+WM). Among the potential predictors tested were
demographic and background variables (age, gender, ethnicity, baseline body mass index,
annual household income, and years of education) and psychosocial variables. Linear
regression was used to assess the association between the total DASH adherence score and
post-treatment clinic-measured BP levels. We first examined improvements in DASH
adherence from pre- to post-treatment as a predictor of BP improvements, controlling for
age, gender, ethnicity, and baseline clinic BP. In a second step, we controlled for the effects
of weight loss in order to assess the association between DASH adherence and BP
improvement over and above change in weight. We also examined the relationship of
adherence to the DASH diet and changes in BP using analysis of variance (ANCOVA),
comparing quartiles of post-treatment BPs adjusting for baseline BPs, change in weight, age,
gender, and ethnicity. All analyses were conducted using SAS version 9.2 (Cary, NC).
Results
Sample Characteristics
One hundred forty-four men (N=47) and women (N=97) were enrolled in the trial, including
40% African American participants (Figure 1). The sample averaged 52 years of age
(SD=10) and were overweight or obese (Mean BMI= 33.1+ 3.9). Of the 144 participants, 67
(47%) had resting clinic BPs >140mm Hg SBP or >90 mm Hg DBP (Mean= 138.1 [95% CI
= 136.7, 139.6] /85.8 [95% CI = 86.8, 84.7] mm Hg). Participants tended to be relatively
well-educated and affluent and there were no treatment group differences on any clinical or
sociodemographic characteristics at baseline. African Americans had lower family income
compared to whites (p=0.03), and were also younger (p=.003) and tended to be less
educated (p=.073) (Table 1).
Adherence to the treatment conditions
DASH dietary class attendance was excellent, with the median number of session attended
12 (92%) in both intervention groups.
Treatment-related Changes in Weight and Aerobic Fitness
As reported previously,7 there were significant treatment group differences in weight change
(p<.0001). Those in the DASH-WM group lost an average of 19 pounds, while weight
remained stable in the DASH-A and UC groups. In addition the DASH+WM group
demonstrated significant improvements in VO2peak (0.22 [95% CI = 0.05, 0.39] L/min
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change), while V02 for the DASH-A (−0.05 [95% CI = −0.15, 0.05] L/min change) and UC
groups (−0.09 [95% CI = −0.19, 0.01] L/min) remained unchanged.
Dietary Habits at Baseline
Compared with the DASH dietary intake recommendations, participants’ baseline diets were
characterized by higher than recommended intake of fat (40% of kcal consumed), saturated
fat (12% kcal), cholesterol (255mg/day), and sodium (2745mg/day); and lower than
recommended intake of protein (15% kcal), fiber (18g/day), potassium (3072mg/day),
magnesium (317mg/day), and calcium (774mg/day) (See appendix for all measured
nutrients). Thus, baseline adherence to the DASH diet was suboptimal in all three groups.
There were no baseline differences in dietary habits between the three treatment groups (p’s
> .05) (Table 2). However, African American participants were less likely to consume foods
consistent with the DASH diet prior to treatment compared to whites (p=0.05). Lower
family income (p=0.05) and younger age (p=0.02) also were associated a lower likelihood of
DASH dietary patterns at baseline, but that differences between African American and white
participants persisted after adjustment for these variables (p=0.03) (Table 3).
Post-treatment Adherence to the DASH Diet
Participants in both the DASH+WM and DASH-A groups demonstrated increased
adherence to the DASH dietary guidelines, as documented by higher DASH adherence
scores compared to the UC group (p<.0001); there was no difference in DASH adherence
between the two DASH treatment groups (p=0.84) (Table 3).
While both African American and white participants increased their consumption of DASH
foods following treatment, African Americans had lower DASH adherence scores following
treatment (p<0.001) (Table 3).
Predictors of Adherence to the DASH Diet
Multiple regression analyses revealed that baseline DASH adherence scores were positively
associated with DASH adherence at 4 months (β=0.23 [95% CI = 0.05, 0.42], p=.015), and
that African Americans reported lower adherence to the DASH diet after treatment
compared to whites (β=−0.39 [95% CI = −0.16, 0.58], p<0.002). Gender (β=−.02 [95% CI =
−0.16, 0.26], p= .843), age (β=.01 [95% CI = −0.20, 0.21], p=.989), years of education (β=.
03 [95% CI = −0.20, 0.20], p=.712), and family income (β=.05 [95% CI = −0.20, 0.22], p=.
582) were not significant predictors of adherence. None of the other clinical or demographic
variables predicted adherence predicted DASH adherence at 4 months. Similarly, none of
the psychosocial measures were predictive of DASH adherence at 4 months, including the
Perceived Social Support Scale, Barrier Scale, Multidimensional Locus of Control, Exercise
Self-Efficacy, Beck Depression Inventory-II, and State-Trait Anxiety Inventory (all ps =
NS).
Dietary Adherence and Blood Pressure
Participants with higher post-treatment DASH adherence scores demonstrated lower clinic
SBP levels after treatment (β=−0.29 [95% CI = −0.42, −0.14], p=.0001). Weight loss was
also related to clinic SBP levels post-intervention (β=0.34 [95% CI = 0.20, 0.47], p <.0001).
When considered in the same regression model, both weight loss and post-treatment DASH
diet adherence independently predicted SBP (DASH adherence score: β=−0.18 [95% CI =
−0.32, −0.03], p=.018; weight loss: β= 0.28 [95% CI = 0.14, 0.42], p= .0002). Each 2-point
increase in DASH diet adherence was associated with a 3.4 mm Hg (95% CI = 2.4, 4.4 mm
Hg) reduction in SBP. Post-treatment DASH adherence scores also predicted lower mean
clinic DBP (β =−0.18 [95% CI = −0.31, −0.04], p=.01). However this association did not
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reach statistical significance after adjusting for weight loss (DASH adherence score: β=
−0.07 [95% CI = −0.21, 0.07], p=.304); weight loss at 4 months independently predicted
lower DBP (β=0.28 [95% CI = 0.14, 0.41], p<.0001), however.
A similar pattern of results were observed for ambulatory BP. Post-treatment DASH
adherence scores were associated with lower SBP (β=−0.20 [95% CI = −0.34, −0.05], p = .
009) at 4 months. Weight loss also was associated with reduced SBP (β=0.28 [95% CI =
0.14, 0.42], p < .001). When considered in the same regression model, weight loss continued
to be associated with lower SBP (β=0.24 [95% CI = 0.10, 0.39], p = .001), while post-
treatment DASH diet adherence was no longer significant (β=−0.12 [95% CI = −0.26, 0.04],
p = .135). Post-treatment DASH adherence scores also predicted lower DBP (β=−0.25 [95%
CI = −0.37, −0.11], p < .001) at 4 months. Weight loss also predicted lower ambulatory DBP
(β=0.25 [95% CI = 0.12, 0.38], p < .001). When considered in the same regression model,
both weight loss and post-treatment DASH diet adherence independently predicted DBP
(DASH adherence score: β=−0.18 [95% CI = −0.31, −0.04], p = .013; weight loss: β=0.19
[95% CI = 0.05, 0.33], p = .007).
Consistent with the above analyses, when quartiles of adherence to the DASH diet were
considered, better adherence to the DASH diet following treatment was associated with
greater reductions in clinic BP. ANCOVA results (adjusting for baseline adherence, age,
ethnicity, gender and baseline BP) revealed Adherence group main effect, such that higher
levels of adherence to the DASH diet were associated with larger clinic BP reductions.
15.6/9.4, 13.4/8.3, 5.9/4.5, 5.2/6.0 mm Hg in Quartiles 1-4 respectively (SBP: p = <.0001;
DBP: p =.004). A similar pattern of results was observed for ambulatory BP: 8.9/5.4,
5.2/2.8, 2.0/0.3, 0.4/−0.5 mm Hg (SBP: p = .024; DBP: p = .002). The mean, post-treatment
clinic and ambulatory BPs, adjusted for baseline BP, age, gender, ethnicity, weight loss, and
pre-treatment DASH adherence are presented in Table 4.
Discussion
The results of this study demonstrate that men and women with high BP are able to adopt
the DASH dietary intake pattern and successfully modify their eating habits over the course
of a 16-week intervention trial. At the outset of the study, the average participant was
consuming a diet reflective of the typical American diet, with elevated intake of fats,
cholesterol, and sodium, and limited intake of fruits and vegetables and low-fat dairy.
Participants in the DASH interventions (DASH-A and DASH+WM) were successful in
increasing consumption of fruits and vegetables and low fat dairy and in decreasing
consumption of fats and saturated fats, sweets and sodium.
Post-intervention DASH adherence was not different between the DASH+WM and DASH-
A groups, despite the added complexity and time commitment of the DASH+WM
intervention compared to those DASH-A participants, who were only required to alter their
dietary intake. One possibility for the similarity between groups was that participation in
aerobic exercise might have improved motivation to adhere to the diet. For example,
exercise may affect dietary change though exercise-induced changes in self-efficacy, self-
regulation, and mood.23 Moreover, potential gains in exercise specific self-efficacy may
have influenced efficacy expectations in the diet domain,24 increasing a sense of personal
agency and ability to comply with the DASH target intake recommendations. Regular
contact with study staff, encouragement of self-monitoring behavior, and education about
diet and BP helped both DASH groups to adopt and maintain the DASH diet pattern.25,26
DASH class attendance in ENCORE was high, with both intervention groups attending a
median number of 12 out of the 14 weekly DASH nutrition classes; however, diet-specific
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adherence rates were less than those seen in the original DASH feeding trials, where full
adherence to the study diets was achieved on 94% of treatment days.2 In the DASH feeding
studies, lack of variety in menus and unappetizing study foods were most often cited by
participants as the main factors hindering adherence.27 Unlike the DASH feeding trials,
however, participants in ENCORE were responsible for menu design and for purchasing and
preparing the food. Moreover, they had to sustain their dietary modifications in a free-living
environment.
Diet-specific adherence rates tended to be higher in the ENCORE trial than those reported in
PREMIER. In PREMIER, participants in the Established plus DASH group increased their
daily intake of fruits and vegetables (7.7 servings: 4 servings of fruit, and 3.7 servings of
vegetables), but not to the extent needed to fully meet the established goals of the trial (9-12
servings). Additionally, sodium intake patterns were quite high at baseline, and remained
higher than the recommended level of 2300 mg/day at 6 months.6 In the ENCORE study,
the average intake of fruits and vegetables across DASH groups was 9.4 servings per day
(5.84 servings of vegetables, 3.60 servings of fruit); and 61% of those in the two DASH
groups were able to reduce their sodium intake to the recommended level of 2400mg per day
or less. Slightly more conservative target intake guidelines in ENCORE may have resulted
in higher overall dietary adherence.
Those individuals who were able to comply with the DASH dietary guidelines in ENCORE
achieved the greatest BP benefits. Adherence to the DASH diet independently predicted
reductions in SBP, with greater diet adherence resulting in more robust changes in SBP.
While it is unclear if there is an optimal “dose” of the DASH eating pattern, greater
adherence to the DASH diet resulted in greater SBP reduction. We noted a 3.4 mm Hg
reduction in SBP for every 2-point increase in overall DASH diet adherence. In a study by
Levitan and colleagues28 greater DASH compliance was associated with lower rates of heart
failure in middle aged and older men. Likewise, in a prospective cohort study in healthy
female nurses, Fung et al.29 found an inverse association between DASH diet adherence and
risk of both cardiovascular disease and stroke. It is important to emphasize that the DASH
diet, independent of exercise or weight loss, was associated with significant BP reductions.
To our knowledge, this is the first study in ‘free living’ participants to demonstrate the value
of the DASH diet in reducing BP independent of other lifestyle changes. However, the
addition of exercise and weight loss to the DASH diet clearly elicited larger BP reductions
and greater improvements in such biomarkers as pulse wave velocity, baroreflex sensitivity,
and left ventricular mass.7 In addition, combining the DASH diet with caloric restriction and
exercise resulted in significant improvements in insulin sensitivity and lipids. Despite the
significant BP reductions associated with DASH-A, the DASH diet without weight loss
resulted in minimal improvements in fasting glucose levels, insulin sensitivity or lipids.30
Thus, it is important for clinicians to encourage not only adherence to the DASH diet, but
also to recognize the added value of exercise and weight loss in overweight or obese patients
with high BP. It also should be emphasized that the ADA suggests that it is more important
to focus on an overall eating pattern rather than specific nutrients or food groups. This
approach is more consistent with the promotion of healthy, positive lifestyle change, and
helps to reduce consumer confusion.31
In an attempt to identify persons who would be likely to be nonadherent with recommended
dietary changes, we assessed a variety of sociodemographic and psychosocial variables as
potential determinants of adherence to the DASH diet. Although participants characterized
by lower levels of exercise self-efficacy, perceived social support, and perceived control
over one’s condition and higher levels of depression and anxiety, and greater perceived
barriers to participation displayed the lowest adherence scores, no psychosocial variable
predicted DASH diet adherence at 4 months.
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Social context puts constraints on choice, and higher socioeconomic status (SES) is
associated with greater adherence to health-promoting behaviors. Research has shown that
persons with lower SES are less likely to engage in healthful activities 32 and individuals
who reside in poorer neighborhoods generally have less access to healthy and diverse food
options (e.g. fresh produce). Moreover, processed foods, which are widely available and
more affordable, are very high in sodium such that 75-80% of salt intake comes from
processed foods.33 While family income was associated with lower baseline diet quality, it
was not predictive of DASH diet adherence at 4 months. Education also has been associated
with more positive health behaviors and fewer risk-reducing behaviors (i.e. increased
physical activity, smoking cessation, sodium and alcohol reduction)32 ; however, education
was unrelated to adherence, perhaps because the majority of participants were college-
educated.
In the present study, we observed ethnic differences in DASH dietary habits at baseline,
with African Americans consuming significantly less low fat dairy products and more
sweets compared to whites. After DASH dietary counseling, African Americans increased
their consumption of DASH foods, but continued to report lower overall adherence to the
DASH eating plan compared to white participants, consuming significantly more meat,
sweets, and fat, and less fruit.
Strong cultural influence on food preferences, food preparation, and perceptions about
eating practices may make it more challenging for African Americans to adhere to the
DASH-diet.34,35 Factors such as high cost of healthy foods, reduced health food availability,
lack of familial support, and less appealing taste of low fat foods may have affected
adherence.36 Prior studies also have highlighted the importance of the eating experience in
fostering a sense of community, and the role food plays in maintaining cultural identity and
preserving tradition.34 In African American culture, particularly those living in the Southern
states, tend to consume what is typically referred to as ‘soul food’, which tends to contain
large amounts of red meat, added fats and spices (e.g., sugar and salt), and may be deep-
fried. These particular food practices are rooted in historical context, and continue to be
passed on through generations due to high intergenerational connectedness.37 In light of the
considerable role food plays in African American culture, greater cultural sensitivity may be
necessary when developing and prescribing dietary modification programs. For example, it
may be more effective to modify traditional ‘soul food’ recipes to meet current nutritional
guidelines rather than to recommend that such foods be eliminated altogether.38 Williams et
al.35 suggest that programs targeting African Americans be culturally relevant and guided by
community participation. The cultural relevance of a particular program can be enhanced
through employing trained community members to deliver the intervention or act as group
leaders or instructors. For example, churches have often served as appropriate and valuable
interventions sites and may offer a setting that could enhance social and familial support,
and a commitment to community health.39,40
Limitations
It should be noted that the research volunteers in ENCORE were highly motivated, as
evidenced by the very low dropout rate suggesting that the study sample may not be fully
representative of typical patients seeking treatment for high BP in clinical practice.
Moreover, in an effort to maximize adherence, participants were closely supervised, and
steps were taken to enhance motivation and reduce barriers to adhere to the program.
Finally, the present study was powered to detect treatment differences in blood pressure and
biomarkers and the present ancillary analyses may not have been adequately powered to
detect significant associations between patient characteristics and DASH diet adherence, or
between individual dietary components of DASH adherence and changes in BP. Further
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research will need to evaluate the extent to which our study findings are generalizable to the
clinic setting.
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Participant flow in the ENCORE clinical trial.
Note: BP- blood pressure; BMI- body mass index (weight in kilograms divided by height in
meters squared); and DASH- Dietary Approaches to Stop Hypertension.
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Table 1







Age, M (SD), y 48.7 (8) 53.8 (10) 51.3 (9)
Gender: Female 47 (83) 50(57) 97 (67)
Level of Education
 High School 19 (34) 29 (33) 48 (33)
 Some College 6 (11) 9 (10) 15 (10)
 Completed College 17 (30) 15 (17) 32 (22)
 Post-Graduate School 9 (16) 26 (30) 35 (24)
 Other 5 (9) 9 (10) 14 (10)
Annual Household Income
 < $20K 8 (17) 9 (12) 17 (12)
 $20-50K 6 (13) 8 (11) 14 (10)
 $50-99K 7 (15) 11 (15) 18 (13)
 > $100K 26 (55) 46 (62) 72 (50)
Weight, M (SD), (kg) 92.4 (14) 93.7 (14) 93.05 (14)
BMI , M (SD), (kg/m2) 34.1 (4.1) 32.5 (3.7) 33.3 (3.9)
Peak VO2, M (SD), mL/kg/min 21.2 (5.7) 24.9 (6.1) 23.1 (5.9)
Peak VO2, M (SD), L/min 1.96 (0.62) 2.32 (0.65) 2.18 (0.66)
Clinic SBP, M (SD), (mmHg) 136.8 (7.1) 138.9 (9.8) 137.9 (8.5)
Clinic DBP, M (SD), (mmHg) 85.8 (6.7) 85.5 (5.7) 85.7 (6.2)
Abbreviations: BMI, body mass index; DASH-A, Dietary Approaches to Stop Hypertension alone; DASH+WM, Dietary Approaches to Stop
Hypertension plus weight management; DBP, diastolic blood pressure; SBP, systolic blood pressure; UC, usual diet controls; VO2, oxygen
consumption
a
African Americans differed from whites on family income (F(1,120)= 4.87, p=0.03), age (F(1,140)= 9.48, p=.003), level of education (F(1,143)=
1.81, P = .073), peak VO2 (F(1,140)= 11.04, P = .001) and gender distribution (F(1,140)=13.68, p<.0003).
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